Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Total Liabilities: 2012-2025

Historic Total Liabilities for CorMedix (CRMD) over the last 11 years, with Sep 2025 value amounting to $376.7 million.

  • CorMedix's Total Liabilities rose 1896.05% to $376.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $376.7 million, marking a year-over-year increase of 1896.05%. This contributed to the annual value of $34.2 million for FY2024, which is N/A change from last year.
  • Latest data reveals that CorMedix reported Total Liabilities of $376.7 million as of Q3 2025, which was up 1,078.43% from $32.0 million recorded in Q2 2025.
  • CorMedix's 5-year Total Liabilities high stood at $376.7 million for Q3 2025, and its period low was $3.9 million during Q1 2021.
  • For the 3-year period, CorMedix's Total Liabilities averaged around $54.0 million, with its median value being $15.2 million (2024).
  • Its Total Liabilities has fluctuated over the past 5 years, first crashed by 32.08% in 2021, then spiked by 1,896.05% in 2025.
  • Over the past 5 years, CorMedix's Total Liabilities (Quarterly) stood at $6.1 million in 2021, then increased by 13.52% to $7.0 million in 2022, then spiked by 42.71% to $8.2 million in 2023, then spiked by 129.41% to $34.2 million in 2024, then soared by 1,896.05% to $376.7 million in 2025.
  • Its Total Liabilities stands at $376.7 million for Q3 2025, versus $32.0 million for Q2 2025 and $34.7 million for Q1 2025.